We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has granted approval to Azurity Pharmaceuticals ...

According to the Centers for Disease Control and Prevention (CDC), about 1 out of 10 people will have a seizure during their lifetime. Most of these seizures will be epileptic seizures, which are ...

The medication is indicated for the treatment of partial-onset seizures in patients one month of age and older.

Please provide your email address to receive an email when new articles are posted on . Fresenius Kabi announced the immediate availability of lacosamide injection, an approved treatment option for ...

Vomiting 2.5 5.9 8.5 Vision blurred 2.5 2.2 8.5 Somnolence 4.7 5.2 8.1 Nasopharyngitis 5.8 6.3 7.6 Fatigue 5.8 7.0 7.2 Coordination abnormal 1.6 4.1 7.2 Tremor 4.1 3.7 6.2 Balance disorder 0.0 1.1 5.1 ...

Credit: Shutterstock. Briviact is now indicated for the treatment of partial-onset seizures in patients 1 month of age and older. The Food and Drug Administration has expanded the approval of Briviact ...

Share on Pinterest A new drug reduced seizures in subjects with treatment resistant epilepsy in a recent clinical trial. The Good Brigade/Getty Images Researchers say a new medication may potentially ...

Lupin receives USFDA approval for generic Brivaracetam Oral Solution to treat seizures, initiating its U.S. market launch.

Although there is currently no cure for epilepsy, treatment can help to control and manage seizures. Treatment may include diet, surgery, medical devices, and medications. There is a wide range of ...

Since 1983, eight new AEDs have been introduced (see Table 2 below). Sadly, a recent VA study of more than 21,000 subjects aged 65 years and older revealed that 80% were being treated with ...

The pharma giant has officially secured USFDA approval for its generic version of the seizure medication Brivaracetam.